Description
Development of a Therapeutic Oncolytic Poxvirus with Enhanced Systemic Delivery and Potency
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02012-04-01$1,953,652
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2012-04-01(start date) | $1,953,652 | — | Development of a Therapeutic Oncolytic Poxvirus with Enhanced Systemic Delivery and Potency |
Related records · 4
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2014-2015-Q4-00181 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $10,944,500 | FY2015 |
| 236-2013-2014-Q4-00040 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $160,000 | FY2015 |
| 236-2013-2014-Q2-00739 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $728,960 | FY2014 |
| 236-2012-2013-Q1-00354 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $318,491 | FY2013 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2011-2012-Q4-00644 · retrieved 2026-11-13.